Outcomes Committee

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 3, 2001, Pages 66-74

  Watkins Bruner, Deborah ^a   Berk, Lawrence ^b   Bondy, Melissa ^c   Kachnic, Lisa A ^d   Konski, Andre ^e   Layne, Elizabeth ^f   Lee, W Robert ^g   Choucair, Ali ^h   Movsas, Benjamin ⁱ   Okunieff, Paul ^j   Roach, Mack ^k   Scott, Charles ^l   Vijayakumar, S ^m   Wenzel, Lari ⁿ  

^a Genitourinary Cancer Committee Liaison   (United States)

^b Community Clinical Oncology Program Committee Liaison ^*  (United States)

^c Epidemiology Subcommittee   (United States)

^d Gastrointestinal Committee Liaison   (United States)

^e Economic Impact Subcommittee   (United States)

^f Patient advocate   (United States)

^g Head and Neck Committee Liaison and Image Guided Radiotherapy Committee Liaison   (United States)

^h Brain Tumor Committee Liaison   (United States)

ⁱ Lung Committee Liaison   (United States)

^j Translational Research Program Committee   (United States)

^k Special Populations Subcommittee   (United States)

^l Statistician   (United States)

^m Radiation Therapy Oncology Group   (United States)

ⁿ Breast and Gynecologic Cancer Committee Liaison   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GENETICS; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; GENETIC MARKER; HEALTH STATUS; HUMAN; LUNG NON SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; ARTICLE; FORECASTING; METHODOLOGY; ONCOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PROFESSIONAL STANDARD;

FORECASTING; HUMANS; ORGANIZATIONAL OBJECTIVES; OUTCOME ASSESSMENT (HEALTH CARE); PROFESSIONAL STAFF COMMITTEES; RADIATION ONCOLOGY; RESEARCH DESIGN;

EID: 0034777092     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01785-0     Document Type: Article

References (17)

1. Geographic variation in the use of breast-conserving treatment for breast cancer
2. Treatment differences and other prognostic factors related to breast cancer and survival: Delivery systems and medical outcomes
3. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer
4. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate
5. Differences in initial treatment patterns and outcomes of lung cancer in the elderly
6. Cost considerations as potential barriers to cancer treatment
7. The NCCN guideline development program
8. Economic analyses in health care: An introduction to the methodology with an emphasis on radiation therapy
9. An outcomes-based management model of patient care
10. Sociodemographic analysis of patients in RTOG clinical trial
11. Effect of advanced age on outcome in Radiation Therapy Oncology Group studies of locally advanced NSCLC
12. Cost-utility analysis of various treatments for non-small cell carcinoma of the lung
13. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): A quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) chemoradiation studies
14. Reliability and validity of the functional assessment of cancer therapy- Lung (FACT-L) quality of life instrument
15. Race and prognosis of brain tumor patients entering multicenter clinical trials: A report from the Radiation Therapy Oncology Group
16. Can costs be measured and predicted by modeling within as cooperative clinical trials group? Economic Methodological Pilot Studies of RTOG (RT0G) Studies 90-03 and 91-04